Back to search

Macrophage Role in the Anti-Prostate Cancer Response to One Class of Antiangiogenic Agents

Data up to Jan 2025

Published1998
Citations117
References39

Total Citations Per Year

Abstract

References (39)

Angiogenesis in cancer, vascular, rheumatoid and other disease

1995 • 7,717 citations

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

1993 • 2,828 citations

Thalidomide is an inhibitor of angiogenesis.

1994 • 2,460 citations

Clinical Cancer Research

1941 • 1,358 citations

Macrophages and angiogenesis

1994 • 1,123 citations

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

1993 • 1,058 citations

Regulators of Angiogenesis

1991 • 959 citations

Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

1993 • 777 citations

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.

1995 • 710 citations

Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.

1990 • 485 citations

Vascular Endothelial Cell Growth Factor Promotes Tyrosine Phosphorylation of Mediators of Signal Transduction That Contain SH2 Domains

1995 • 480 citations

Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization

1997 • 447 citations

Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers

1986 • 412 citations

The Molecular Basis of Cancer

1985 • 389 citations

Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.

1984 • 366 citations

Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.

1987 • 286 citations

Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.

1997 • 215 citations

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1994 • 159 citations

Lipopolysaccharide‐induced cytokine production in human monocytes: Role of tyrosine phosphorylation in transmembrane signal transduction

1994 • 158 citations

IL-12 regulates VEGF and MMPs in a murine breast cancer model

1998 • 138 citations

Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.

1993 • 131 citations

Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation.

1990 • 112 citations

Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer.

1995 • 106 citations

Antiangiogenic effects of the quinoline-3-carboxamide linomide.

1993 • 104 citations

Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.

1997 • 102 citations

Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.

1995 • 99 citations

Plasminogen activator system in human breast cancer

1992 • 78 citations

Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.

1996 • 57 citations

Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.

1995 • 56 citations

The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.

1992 • 56 citations

Urokinase Plasminogen Activator Induces Angiogenesis and Tumor Vessel Invasion in Breast Cancer

1995 • 44 citations

Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers

1995 • 40 citations

Macrophage colony-stimulating factor and granulocyte-macrophage colony- stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes

1993 • 37 citations

Anti-Angiogenic Treatment with Linomide as Adjuvant to Surgical Castration in Experimental Prostate Cancer

1997 • 27 citations

The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor

1996 • 20 citations

Studies on tumor induced angiogenesis

1992 • 17 citations

The antiangiogenic agent linomide inhibits tumor necrosis factor-α secretion via inhibition of its synthesis

1996 • 16 citations

Production of plasminogen activator inhibitor type-2 in human peripheral blood monocytes upregulated in vitro by the quinoline-3-carboxamide, Linomide

1996 • 6 citations

Cited By (0)

No citing papers found in database

Macrophage Role in the Anti-Prostate Cancer Response to One Class of Antiangiogenic Agents (1998) – JNCI Journal of the National Cancer Institute | Metascience Observatory Explorer